Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)

NCT02959853 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Hypogonadism
Severe Obesity

Interventions

DRUG: Anastrazole
BEHAVIORAL: weight loss

Sponsor

Baylor College of Medicine